 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/19/2023 |
$148.95 |
$150.54 |
$147.33 |
$148.71 |
7.17M | | 01/20/2023 |
$149.43 |
$149.71 |
$147.15 |
$149.59 |
7.06M | | 01/23/2023 |
$149.86 |
$150.43 |
$148.05 |
$148.55 |
7.62M | | 01/24/2023 |
$148.08 |
$148.87 |
$146.44 |
$147.69 |
5.17M | | 01/25/2023 |
$147.38 |
$147.98 |
$146.50 |
$147.79 |
5.74M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and The Juvederm Collection of Fillers; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon and Synthroid. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on January 19, 2023, ABBV opened at $148.95, traded as high as $150.54 and as low as $147.33, and closed at $148.71. Trading volume was a total of 7.17M shares. On January 20, 2023, ABBV opened at $149.43, traded as high as $149.71 and as low as $147.15, and closed at $149.59. Trading volume was a total of 7.06M shares. On January 23, 2023, ABBV opened at $149.86, traded as high as $150.43 and as low as $148.05, and closed at $148.55. Trading volume was a total of 7.62M shares. On January 24, 2023, ABBV opened at $148.08, traded as high as $148.87 and as low as $146.44, and closed at $147.69. Trading volume was a total of 5.17M shares. On January 25, 2023, ABBV opened at $147.38, traded as high as $147.98 and as low as $146.50, and closed at $147.79. Trading volume was a total of 5.74M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/29/2013 |
|
| End date: |
01/25/2023 |
|
| Start price/share: |
$37.31 |
|
| End price/share: |
$147.79 |
|
| Starting shares: |
268.02 |
|
| Ending shares: |
403.05 |
|
| Dividends reinvested/share: |
$34.63 |
|
| Total return: |
495.67% |
|
| Average Annual Total Return: |
19.55% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$59,575.94 |
|
| Years: |
9.99 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/29/2013 |
|
| End date: |
01/25/2023 |
|
| Start price/share: |
$37.31 |
|
| End price/share: |
$147.79 |
|
| Dividends collected/share: |
$34.63 |
|
| Total return: |
388.93% |
|
| Average Annual Total Return: |
17.21% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$48,895.49 |
|
| Years: |
9.99 |
|
|
|
| Date |
Close |
| 01/19/2023 | $148.71 | | 01/20/2023 | $149.59 | | 01/23/2023 | $148.55 | | 01/24/2023 | $147.69 | | 01/25/2023 | $147.79 |
|
|
Free ABBV Email Alerts:
